Benefit and risk from paclitaxel-coated balloon angioplasty for the treatment of femoropopliteal artery disease: A systematic review and meta-analysis of randomised controlled trials

BACKGROUND: Paclitaxel-coated balloons (DCB) are suitable to reduce the risk of restenosis after angioplasty of atherosclerotic femoropopliteal lesions. However, numerous types of DCBs are distinguished by drug density and coating. Conflicting evidence exists about the risk of mortality. This study...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:EClinicalMedicine
Glavni autori: Klumb, Christof, Lehmann, Thomas, Aschenbach, René, Eckardt, Niklas, Teichgräber, Ulf
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2019
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6890981/
https://ncbi.nlm.nih.gov/pubmed/31832619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.09.004
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items